Immunovant, Inc. Increase (Decrease) in Accounts Receivable
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- Immunovant, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$436.00K.
- Immunovant, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$563.00K.
- Immunovant, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$319.00K, a 261.93% decline year-over-year.
- Immunovant, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $25.00K.
- Immunovant, Inc. increase (decrease) in accounts receivable for fiscal 2026 was -$986.00K.
- Immunovant, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$3.23M, a 170.61% decline from fiscal 2024.
- Immunovant, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $4.58M.
- Immunovant, Inc. increase (decrease) in accounts receivable for fiscal 2023 was -$11.76M, a 201.13% decline from fiscal 2022.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$436.00K 10-Q · filed 2026-08-06 | -$999.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.32M derived: sum of 3 quarters · filed 2026-08-06 | -$1.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$563.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | -$882.00K derived: sum of 2 quarters · filed 2026-05-20 | -$857.00K derived: sum of 3 quarters · filed 2026-05-20 | -$986.00K 10-K · filed 2026-05-20 |
| 2025-12-31 | -$319.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | -$294.00K derived: sum of 2 quarters · filed 2026-02-06 | -$423.00K 10-Q · filed 2026-02-06 | -$508.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | -$104.00K 10-Q · filed 2025-11-10 | -$189.00K derived: sum of 3 quarters · filed 2026-08-06 | $8.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$129.00K 10-Q · filed 2026-08-06 | -$214.00K derived: sum of 2 quarters · filed 2026-08-06 | -$17.00K derived: sum of 3 quarters · filed 2026-08-06 | -$434.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $112.00K derived: sum of 2 quarters · filed 2026-05-20 | -$305.00K derived: sum of 3 quarters · filed 2026-05-20 | -$3.23M 10-K · filed 2026-05-20 |
| 2024-12-31 | $197.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | -$220.00K derived: sum of 2 quarters · filed 2026-02-06 | -$3.15M 10-Q · filed 2026-02-06 | $993.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-09-30 | -$417.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10 | -$3.34M 10-Q · filed 2025-11-10 | $796.00K derived: sum of 3 quarters · filed 2026-05-20 | $530.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-06-30 | -$2.93M 10-Q · filed 2025-08-11 | $1.21M derived: sum of 2 quarters · filed 2026-05-20 | $947.00K derived: sum of 3 quarters · filed 2026-05-20 | $1.51M derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-03-31 | $4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $3.87M derived: sum of 2 quarters · filed 2026-05-20 | $4.43M derived: sum of 3 quarters · filed 2026-05-20 | $4.58M 10-K · filed 2026-05-20 |
| 2023-12-31 | -$266.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06 | $295.00K derived: sum of 2 quarters · filed 2025-02-06 | $437.00K 10-Q · filed 2025-02-06 | $435.00K derived: sum of 4 quarters · filed 2025-05-29 |
| 2023-09-30 | $561.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $703.00K 10-Q · filed 2024-11-07 | $701.00K derived: sum of 3 quarters · filed 2025-05-29 | -$2.24M derived: sum of 4 quarters · filed 2025-05-29 |
| 2023-06-30 | $142.00K 10-Q · filed 2024-08-06 | $140.00K derived: sum of 2 quarters · filed 2025-05-29 | -$2.81M derived: sum of 3 quarters · filed 2025-05-29 | -$12.57M derived: sum of 4 quarters · filed 2025-05-29 |
| 2023-03-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | -$2.95M derived: sum of 2 quarters · filed 2025-05-29 | -$12.71M derived: sum of 3 quarters · filed 2025-05-29 | -$11.76M 10-K · filed 2025-05-29 |
| 2022-12-31 | -$2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | -$12.71M derived: sum of 2 quarters · filed 2024-02-12 | -$11.76M 10-Q · filed 2024-02-12 | -$8.05M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-09-30 | -$9.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09 | -$8.82M 10-Q · filed 2023-11-09 | -$5.10M derived: sum of 3 quarters · filed 2023-11-09 | $2.43M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $947.00K 10-Q · filed 2023-08-10 | $4.66M derived: sum of 2 quarters · filed 2023-08-10 | $12.19M derived: sum of 3 quarters · filed 2023-08-10 | $12.37M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-22 | $11.25M derived: sum of 2 quarters · filed 2023-05-22 | $11.42M derived: sum of 3 quarters · filed 2023-05-22 | $11.63M 10-K · filed 2023-05-22 |
| 2021-12-31 | $7.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-03 | $7.71M derived: sum of 2 quarters · filed 2023-02-03 | $7.92M 10-Q · filed 2023-02-03 | |
| 2021-09-30 | $177.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-04 | $387.00K 10-Q · filed 2022-11-04 | ||
| 2021-06-30 | $210.00K 10-Q · filed 2022-08-05 | |||
| 2021-03-31 | $596.00K 10-K · filed 2022-06-08 |